Skip to main content
Download PDF
- Main
COVID-19 and CAR-T cells: current challenges and future directions-a report from the EPICOVIDEHA survey by EHA-IDWP
- Busca, Alessandro;
- Salmanton-García, Jon;
- Corradini, Paolo;
- Marchesi, Francesco;
- Cabirta, Alba;
- Di Blasi, Roberta;
- Dulery, Remy;
- Lamure, Sylvain;
- Farina, Francesca;
- Weinbergerová, Barbora;
- Batinić, Josip;
- Nordlander, Anna;
- López-García, Alberto;
- Drgoňa, Ľuboš;
- Espigado-Tocino, Ildefonso;
- Falces-Romero, Iker;
- García-Sanz, Ramón;
- García-Vidal, Carolina;
- Guidetti, Anna;
- Khanna, Nina;
- Kulasekararaj, Austin;
- Maertens, Johan;
- Hoenigl, Martin;
- Klimko, Nikolai;
- Koehler, Philipp;
- Pagliuca, Antonio;
- Passamonti, Francesco;
- Cornely, Oliver A;
- Pagano, Livio
- et al.
Published Web Location
https://doi.org/10.1182/bloodadvances.2021005616Abstract
The EHA-IDWP developed an observational registry collecting data on COVID-19 infection in patients who received CAR T-cell therapy. Prevalence of COVID-19 was 4.8%, and overall mortality was 50%, highlighting the need for prevention of infection in these patients.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
For improved accessibility of PDF content, download the file to your device.
Enter the password to open this PDF file:
File name:
-
File size:
-
Title:
-
Author:
-
Subject:
-
Keywords:
-
Creation Date:
-
Modification Date:
-
Creator:
-
PDF Producer:
-
PDF Version:
-
Page Count:
-
Page Size:
-
Fast Web View:
-
Preparing document for printing…
0%